BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 8692280)

  • 1. Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.
    Cunha RA; Johansson B; Constantino MD; SebastiĆ£o AM; Fredholm BB
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):261-71. PubMed ID: 8692280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further characterization of [3H]-CGS 21680 binding sites in the rat striatum and cortex.
    Kirk IP; Richardson PJ
    Br J Pharmacol; 1995 Jan; 114(2):537-43. PubMed ID: 7881753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G protein coupling of CGS 21680 binding sites in the rat hippocampus and cortex is different from that of adenosine A1 and striatal A2A receptors.
    Cunha RA; Constantino MD; Ribeiro JA
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):295-302. PubMed ID: 10344528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.
    Zocchi C; Ongini E; Ferrara S; Baraldi PG; Dionisotti S
    Br J Pharmacol; 1996 Apr; 117(7):1381-6. PubMed ID: 8730729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding of the adenosine A2 receptor selective agonist [3H]CGS 21680 to rat cortex differs from its binding to rat striatum.
    Johansson B; Georgiev V; Parkinson FE; Fredholm BB
    Eur J Pharmacol; 1993 Oct; 247(2):103-10. PubMed ID: 8281998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
    Jarvis MF; Schulz R; Hutchison AJ; Do UH; Sills MA; Williams M
    J Pharmacol Exp Ther; 1989 Dec; 251(3):888-93. PubMed ID: 2600819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists.
    Maemoto T; Finlayson K; Olverman HJ; Akahane A; Horton RW; Butcher SP
    Br J Pharmacol; 1997 Nov; 122(6):1202-8. PubMed ID: 9401787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a low affinity binding site for N6-substituted adenosine derivatives in rat testis membranes.
    Mazzoni MR; Buffoni RS; Giusti L; Lucacchini A
    J Recept Signal Transduct Res; 1995; 15(7-8):905-29. PubMed ID: 8673723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
    Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB
    Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
    Alexander SP; Curtis AR; Kendall DA; Hill SJ
    Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of 5'-N-ethylcarboxamidoadenosine on evoked release of [3H]serotonin in the rat nucleus tractus solitarius.
    Helfman CC; Zhong H; Barraco RA; Anderson GF
    Neurosci Lett; 1996 Jul; 213(1):61-5. PubMed ID: 8844713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential development of adenosine A1 and A2b receptors in the rat duodenum.
    Peachey JA; Hourani SM; Kitchen I
    Br J Pharmacol; 1996 Nov; 119(5):949-58. PubMed ID: 8922745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further characterization of the binding of the adenosine receptor agonist [3H]CGS 21680 to rat brain using autoradiography.
    Johansson B; Fredholm BB
    Neuropharmacology; 1995 Apr; 34(4):393-403. PubMed ID: 7566470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of A1 and A2a adenosine receptor binding in aged striatum, hippocampus and cortex of the rat.
    Cunha RA; Constantino MC; SebastiĆ£o AM; Ribeiro JA
    Neuroreport; 1995 Jul; 6(11):1583-8. PubMed ID: 7579154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.
    Jacobson KA; Stiles GL; Ji XD
    Mol Pharmacol; 1992 Jul; 42(1):123-33. PubMed ID: 1635550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competition of adenine nucleotides for a 1,3-[3H]-dipropyl-8-cyclopentylxanthine binding site in rat vas deferens.
    Smith AD; Cheek DJ; Buxton IL; Westfall DP
    Clin Exp Pharmacol Physiol; 1997 Jul; 24(7):492-7. PubMed ID: 9248666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.
    Ferre S; von Euler G; Johansson B; Fredholm BB; Fuxe K
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7238-41. PubMed ID: 1678519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the binding of a novel nonxanthine adenosine antagonist radioligand, [3H]CGS 15943, to multiple affinity states of the adenosine A1 receptor in the rat cortex.
    Jarvis MF; Williams M; Do UH; Sills MA
    Mol Pharmacol; 1991 Jan; 39(1):49-54. PubMed ID: 1987452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes.
    Nonaka H; Mori A; Ichimura M; Shindou T; Yanagawa K; Shimada J; Kase H
    Mol Pharmacol; 1994 Nov; 46(5):817-22. PubMed ID: 7969067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of human striatal A2-adenosine receptors using radioligand binding and photoaffinity labeling.
    Ji XD; Stiles GL; van Galen PJ; Jacobson KA
    J Recept Res; 1992; 12(2):149-69. PubMed ID: 1583620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.